Estimated Glomerular Filtration Rate Is Associated With an Increased Risk of Death in Heart Failure Patients With Preserved Ejection Fraction
Open Access
- 26 April 2021
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Cardiovascular Medicine
- Vol. 8
Abstract
Background: Renal dysfunction is associated with adverse cardiovascular outcomes in patients with heart failure (HF), but its impact on patients with heart failure with preserved ejection fraction (HFpEF) remains unclear.Methods: 3,392 subjects of the TOPCAT (Treatment of Preserved Cardiac Function Heart Failure with an Aldosterone Antagonist) trial were assigned to two groups by estimated glomerular filtration rate (eGFR) ≥ 60 ml/min/1.73 m2 or 30–59 ml/min/1.73 m2. The outcomes, including all-cause death, cardiovascular death and HF hospitalization, were examined by multivariable cox models.Results: Over a median follow-up of 3.4 ± 1.7 years, a total of 524 all-cause deaths, 334 cardiovascular deaths and 440 HF hospitalizations occurred. Compared with patients with eGFR ≥ 60 ml/min/1.73 m2, those with eGFR 30–59 ml/min/1.73 m2 were associated with an increased risk of the all-cause death [adjusted hazard ratio (HR), 1.47; 95% confidence interval (CI), 1.24–1.76; P < 0.001], cardiovascular death (adjusted HR, 1.53; 95% CI: 1.23–1.91; p < 0.001), and HF hospitalization (adjusted HR: 1.21; 95% CI: 1.00–1.47; p = 0.049) after multivariable adjustment for potential confounders.Conclusions: eGFR 30–59 ml/min/1.73 m2 was related to an increased risk of all-cause death, cardiovascular death and HF hospitalization in HFpEF patients.Keywords
This publication has 30 references indexed in Scilit:
- Trajectories of Renal Function During Heart Failure Hospitalization: Beware the Bumpy Ride!Journal of Cardiac Failure, 2019
- Clinical impacts of changes of renal function during hospitalization depend on grades of renal dysfunction in acute decompensated heart failureHeart and Vessels, 2019
- Heart Failure With Preserved Ejection Fraction In PerspectiveCirculation Research, 2019
- Associations With and Prognostic Impact of Chronic Kidney Disease in Heart Failure With Preserved, Mid-Range, and Reduced Ejection FractionEuropean Journal of Heart Failure, 2017
- Phenotype-Specific Treatment of Heart Failure With Preserved Ejection FractionCirculation, 2016
- Association of Chronic Kidney Disease with Abnormal Cardiac Mechanics and Adverse Outcomes in Patients with Heart Failure and Preserved Ejection FractionEuropean Journal of Heart Failure, 2015
- Coronary Microvascular Rarefaction and Myocardial Fibrosis in Heart Failure With Preserved Ejection FractionCirculation, 2015
- Spironolactone for Heart Failure with Preserved Ejection FractionNew England Journal of Medicine, 2014
- A Novel Paradigm for Heart Failure With Preserved Ejection FractionJACC, 2013
- Renal Impairment and Outcomes in Heart FailureJACC, 2006